“Aricept “appears to have beneficial effects on retention of training on complex aviation tasks in nondemented older adults,” and these findings were ultimately published in Neurology. There is already a major pharmacologic market for physical performance-enhancing drugs. With an aging population, interest in medications for cognitive enhancement will likely grow.”

“Aricept “appears to have beneficial effects on retention of training on complex aviation tasks in nondemented older adults,” and these findings were ultimately published in Neurology. There is already a major pharmacologic market for physical performance-enhancing drugs. With an aging population, interest in medications for cognitive enhancement will likely grow.”

— Rahul Jandial